ClinicalTrials.gg
Sign In

Sinusitis clinical trials

The registry lists 256 studies for Sinusitis across more than 10 countries. 23 are recruiting or about to start. 191 of them are mainly about Sinusitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Rhinosinusitis too: 490 studies, 91 open.

Get an email when these change. Save the Sinusitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
152
Status unknown
34
Terminated
21
Withdrawn
15
Recruiting
15
Active, not recruiting
10

Phase

Phase 4
37
Phase 3
34
Phase 2
29
Phase 1
10
Early Phase 1
1

Where

United States
129
Canada
27
China
14
Egypt
9
Germany
8
France
7

Who runs them

Integra LifeSciences Corporation (8) · St. Paul's Hospital, Canada (7) · Intersect ENT (7) · Entellus Medical, Inc. (5) · GlaxoSmithKline (5) · Bayer (4) · University of Chicago (4) · STS Medical (3)

What is being tested here

Drugs under test in Sinusitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Amoxicillin218
Azithromycin116
Clavulanic Acid115
Budesonide115
Dupilumab104
Amoxicillin-Potassium Clavulanate Combination114
Omalizumab113
Moxifloxacin013
Telithromycin013
Camtarkibart012

Drug classes tested here Beta-lactamase inhibitors 2 open · Corticosteroids 1 open

Coming up

2phase 3 studies under way
9studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 15 Sinusitis studies recruiting now, 6 (40%) set no upper age limit and 6 (40%) stop at 75 or younger. 2 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
102 (13%)2 (13%)
1813 (87%)13 (87%)
3013 (87%)13 (87%)
4013 (87%)13 (87%)
5013 (87%)13 (87%)
6514 (93%)14 (93%)
7511 (73%)11 (73%)
857 (47%)7 (47%)

Across all 256 studies, recruiting or not: 36% stop at 75 or younger and 20% at 65; 21% take children; 0% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Sinusitis studies take

Of 29 interventional studies with no phase under Sinusitis, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase19 mo9–63 · 29 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 256. Browse all 256 → or search them.